by Team Small News | Sep 14, 2025 | Pharma, Zydus
India’s outward foreign direct investment (FDI) has seen a significant decline in August, dropping to $2.1 billion from $3.4 billion in the same month last year. This represents a 38% decrease year-over-year. Compared to the previous month, the decline is even...
by Team Small News | Sep 14, 2025 | Pharma, Zydus
A Central Drugs Standard Control Organisation (CDSCO) panel has rejected Zydus’ request for a phase III clinical trial (CT) waiver for their proposed COVID-19 vaccine. The decision was based on the panel’s findings that the available data on the...
by Team Small News | Sep 14, 2025 | Aurobindo Pharma, Biocon, Cipla, Glenmark, Lupin, Mankind, Pharma, Sun Pharma, Torrent Pharma, Zydus
The pharmaceutical industry is complex, with various segments such as innovator products, generics, branded generics, and API. Indian companies are making headway globally, and understanding the industry’s intricacies is crucial for those seeking opportunities....
by Team Small News | Sep 13, 2025 | Pharma, Zydus
The Indian Council of Medical Research (ICMR) has been driving efforts to indigenize vaccine development in India, leveraging advanced technologies such as artificial intelligence (AI). This initiative aims to enhance the country’s self-reliance in vaccine...
by Team Small News | Sep 3, 2025 | Pharma, Zydus
The global market for seasonal influenza vaccines is expected to experience significant growth, with a projected value of $24.1 billion by 2035, up from $10.2 billion in 2025, at a compound annual growth rate (CAGR) of 9%. Major multinational vaccine manufacturers,...
by Team Small News | Sep 2, 2025 | Pharma, Sun Pharma, Torrent Pharma, Zydus
Gujarat is playing a vital role in India’s pharmaceutical industry, driven by government initiatives and investment opportunities. The state is home to major pharmaceutical companies such as Sun Pharma, Zydus Cadila, and Intas Pharmaceuticals, contributing...